Bone Formation, Growth Plate & Skeletal Dysplasias
How cartilage becomes bone, and what FGFR3, RUNX2 and GNAS mutations do to it
How bone forms
Two routes. Bone forms either by replacing a cartilage model (endochondral ossification) or directly from mesenchyme (intramembranous ossification). Both depend on osteoblasts, whose differentiation is switched on by the transcription factor RUNX2.
| Feature | Endochondral | Intramembranous |
|---|---|---|
| Template | Hyaline cartilage model | None: mesenchymal cells become osteoblasts directly |
| Bones built | Long bones, vertebrae, pelvis, skull base | Skull vault (e.g., parietal bones), facial bones, clavicle |
| Growth role | Lengthens bones at the growth plate | Widens bones by periosteal apposition |
| Classic defect | FGFR3 activation (achondroplasia) | RUNX2 haploinsufficiency (cleidocranial dysplasia) |
Ossification centers. In the fetus a primary center forms in the diaphysis: chondrocytes hypertrophy, the matrix calcifies, vessels invade and osteoblasts lay bone on the calcified cartilage. After birth, secondary centers ossify the epiphyses. The cartilage left between them, the growth plate (physis), lengthens the bone until it fuses after puberty. Bone age on a left-hand radiograph reflects when these centers appear and fuse: delayed in hypothyroidism and GH deficiency, advanced in precocious puberty.
Woven versus lamellar bone. Woven bone is deposited quickly with haphazard collagen; it is normal in the fetal skeleton and fracture callus but mechanically weak. Remodeling replaces it with lamellar bone, whose parallel collagen sheets form osteons in cortical bone and trabeculae in spongy bone. Woven bone in an adult outside a healing fracture signals disease such as Paget disease, fibrous dysplasia or a bone-forming tumor.
The growth plate and its control
- Reserve (resting) zoneQuiescent chondrocytes next to the epiphysis
- Proliferative zoneChondrocytes divide in stacked columns; GH/IGF-1 stimulate and FGFR3 restrains this step
- Hypertrophic zoneCells swell and secrete type X collagen and VEGF; the weakest layer
- Zone of calcificationMatrix mineralizes and chondrocytes die
- Zone of ossificationVessels bring osteoblasts that lay woven bone on calcified cartilage spicules
Clinical links. Salter-Harris physeal fractures and slipped capital femoral epiphysis shear through the hypertrophic zone. In rickets, failed mineralization leaves the physis wide and frayed.
Hormones. Growth hormone acts mainly through IGF-1, made in the liver and locally in cartilage, to drive chondrocyte proliferation; thyroid hormone is required for chondrocyte maturation. At puberty sex steroids produce the growth spurt, and estrogen, made from testosterone by aromatase in males, closes the physis in both sexes. Men lacking aromatase or estrogen receptor-α keep open growth plates and keep growing into adulthood. GH excess before fusion causes gigantism; after fusion it causes acromegaly.
FGFR3 disorders
Achondroplasia. FGFR3 normally brakes chondrocyte proliferation. A gain-of-function mutation (G380R in about 98% of cases) overdrives the brake, so endochondral growth fails while intramembranous and periosteal bone form normally. Inheritance is autosomal dominant, but about 80% of cases are de novo and linked to advanced paternal age; homozygosity is lethal. Children have rhizomelic (humerus and femur) shortening, macrocephaly with frontal bossing and midface hypoplasia, trident hands, genu varum and lumbar lordosis, with normal trunk length and intelligence. Vosoritide, a C-type natriuretic peptide analog, counters FGFR3 signaling and increases growth velocity while the physes are open.
A narrow foramen magnum can compress the cervicomedullary junction in infancy, causing central apnea and sudden death. Obstructive sleep apnea, recurrent otitis media and adult spinal stenosis follow later.
Thanatophoric dysplasia. Stronger FGFR3 activation causes the most common lethal skeletal dysplasia: extreme micromelia, flattened vertebrae and a narrow thorax lead to pulmonary hypoplasia and neonatal death. Type I has curved "telephone-receiver" femurs; type II has straight femurs and a cloverleaf skull. The FGFR3 spectrum runs from hypochondroplasia (mild) through achondroplasia to thanatophoric dysplasia.
RUNX2 and GNAS disorders
Cleidocranial dysplasia. Autosomal dominant loss of one RUNX2 (CBFA1) allele impairs osteoblast differentiation, most visibly in membranous bones. The clavicles are hypoplastic or absent, so the shoulders can meet in front of the chest; fontanelles and sutures stay open, with Wormian bones; supernumerary teeth erupt late.
Fibrous dysplasia. A postzygotic activating GNAS mutation makes Gsα constitutively active and raises cAMP. Marrow is replaced by fibroblastic tissue with curved trabeculae of woven bone lacking osteoblastic rims ("Chinese letters"). Radiographs show expansile ground-glass lesions, and repeated fractures of the proximal femur create a shepherd's crook deformity. Most cases are monostotic (ribs, femur, craniofacial bones).
McCune-Albright syndrome. An earlier, mosaic GNAS mutation produces polyostotic fibrous dysplasia, café-au-lait macules with jagged "coast of Maine" borders that respect the midline, and autonomous endocrine hyperfunction: classically GnRH-independent precocious puberty with suppressed LH and FSH, plus hyperthyroidism, GH excess, Cushing syndrome or FGF23-driven phosphate wasting.
Constitutive Gsα activation in every cell is lethal, so patients survive only as mosaics. Smooth "coast of California" café-au-lait spots point to NF1 instead.
Dysplasia versus brittle bone
The fracture distractor. Recurrent low-trauma fractures suggest osteogenesis imperfecta, a type I collagen defect (COL1A1/COL1A2) with blue sclerae, hearing loss and dentinogenesis imperfecta, or, in a child, nonaccidental trauma. Growth plate dysplasias change bone length and shape rather than making bone brittle, and fibrous dysplasia fractures only through its lesions.
| Disorder | Gene and effect | Inheritance | Hallmarks |
|---|---|---|---|
| Achondroplasia | FGFR3 gain of function | AD, ~80% de novo | Rhizomelia, macrocephaly, normal trunk |
| Thanatophoric dysplasia | Stronger FGFR3 activation | De novo, lethal | Micromelia, narrow thorax, telephone-receiver femurs |
| Cleidocranial dysplasia | RUNX2 haploinsufficiency | AD | Absent clavicles, open fontanelles, extra teeth |
| McCune-Albright syndrome | Activating GNAS (Gsα) | Postzygotic mosaic | Polyostotic fibrous dysplasia, coast-of-Maine spots, precocious puberty |
| Osteogenesis imperfecta | COL1A1/COL1A2 (type I collagen) | Mostly AD | Fractures, blue sclerae, hearing loss |